Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Hum Mutat. 2018 Nov;39(11):1677–1685. doi: 10.1002/humu.23631

Table 1:

ClinGen Actionability Working Group semi-quantitative score metric (Originally published in Hunter et, 2016, scoring metric adapted from Berg et al, 2016)

Domain Scores
Severity: What is the nature of the threat to health to an individual carrying a clearly deleterious allele in this gene? 3 = Reasonable possibility of sudden death
2 = Reasonable possibility of death or major morbidity
1 = Modest morbidity
0 = Minimal or no morbidity
Likelihood of disease: What is the chance that a serious outcome will materialize given a deleterious variant (akin to penetrance)? 3 = >40% chance
2 = 5–39% chance
1 = 1–4% chance
0 = <1% chance
Effectiveness of specific interventions: How effective is the selected, specific intervention for preventing or significantly diminishing the risk of harm? 3 = Highly effective
2 = Moderately effective
1 = Minimally effective
0 = Controversial or unknown effectiveness
IN = Ineffective/No intervention
Nature of intervention: How risky, medically burdensome, or intensive is a given intervention? 3 = Low risk, or medically acceptable and low-intensity interventions
2 = Moderate risk, moderately acceptable or intensive interventions
1 = Greater risk, less acceptable and substantial interventions
0 = High risk, poorly acceptable or intensive interventions
State of the knowledge base: What is the level of evidence? A = Substantial evidence, or evidence from a high tier (Tier 1)
B = Moderate evidence, or evidence from a moderate tier (Tier 2)
C = Minimal evidence, or evidence from a lower tier (Tier 3 or 4)
D = Poor evidence, or evidence not provided in the report
E = Evidence based on expert contributions (Tier 5)

† Do not score the remaining categories.

‡ Tier 1: Evidence from a systematic review/meta-analysis or a clinical practice guideline clearly based on a systematic review; Tier 2: Evidence from clinical practice guidelines using expert consensus; Tiers 3 and 4: Evidence from a non-systematic review of evidence with additional primary literature cited (Tier 3) or not cited (Tier 4); Tier 5: Expert contribution or non-systematically identified evidence.